Gene · 5818
Papers3,675
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,675
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| dsRNA-induced immunity targets plasmodesmata and is suppressed by viral movement proteins. | Plant Cell | 2023 | 37378592 | PubTator, text mining | PubMed |
| CLEAR Strategy Inhibited HSV Proliferation Using Viral Vectors Delivered CRISPR-Cas9. | Pathogens | 2023 | 37375504 | PubTator, text mining | PubMed |
| Possible Therapeutic Mechanisms and Future Perspectives of Vaginal Microbiota Transplantation. | Microorganisms | 2023 | 37374929 | PubTator, text mining | PubMed |
| Research Progress of Dendritic Cell Surface Receptors and Targeting. | Biomedicines | 2023 | 37371768 | PubTator, text mining | PubMed |
| Cell-Free Supernatant Derived from a Lactobacillus casei BL23 Culture Modifies the Antiviral and Immunomodulatory Capacity of Mesenchymal Stromal Cells. | Biomedicines | 2023 | 37371616 | PubTator, text mining | PubMed |
| The Effects of a High-Fat Diet on Inflammatory Bowel Disease. | Biomolecules | 2023 | 37371485 | PubTator, text mining | PubMed |
| Construction of a T-cell exhaustion-related gene signature for predicting prognosis and immune response in hepatocellular carcinoma. | Aging (Albany NY) | 2023 | 37354485 | PubTator, text mining | PubMed |
| Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer. | Cancers (Basel) | 2023 | 37345069 | PubTator, text mining | PubMed |
| Novel nanoadjuvants balance immune activation with modest inflammation: implications for older adult vaccines. | Immun Ageing | 2023 | 37344886 | PubTator, text mining | PubMed |
| Comprehensive immunoprofiling and systematic adjuvant comparisons for identifying suitable vaccine: Adjuvant pairings. | Hum Vaccin Immunother | 2023 | 37341528 | PubTator, text mining | PubMed |
| Serum levels of high mobility group box-1 protein (HMGB1) and soluble receptors of advanced glycation end-products (RAGE) in depressed patients treated with electroconvulsive therapy. | Neuropsychopharmacol Rep | 2023 | 37337402 | PubTator, text mining | PubMed |
| Potential Alternative Therapeutic Modalities for Management Head and Neck Squamous Cell Carcinoma: A Review. | Cancer Control | 2023 | 37328298 | PubTator, text mining | PubMed |
| Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells. | Front Cell Infect Microbiol | 2023 | 37325516 | PubTator, text mining | PubMed |
| Rejection of Lepeophtheirus salmonis driven in part by chitin sensing is not impacted by seawater acclimitization in Coho salmon (Oncorhynchus kisutch). | Sci Rep | 2023 | 37322246 | PubTator, text mining | PubMed |
| Dual pattern recognition receptor ligands CL401, CL413, and CL429 as adjuvants for inactivated chikungunya virus. | Virology | 2023 | 37321145 | PubTator, text mining | PubMed |
| An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation. | Mol Cell | 2023 | 37311461 | PubTator, text mining | PubMed |
| The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression. | Int J Mol Sci | 2023 | 37298370 | PubTator, text mining | PubMed |
| Chronic Kidney Disease Transdifferentiates Veins into a Specialized Immune-Endocrine Organ with Increased MYCN-AP1 Signaling. | Cells | 2023 | 37296603 | PubTator, text mining | PubMed |
| Temperature impacts Atlantic salmon's (Salmo salar) immunological response to infectious salmon anemia virus (ISAv). | Fish Shellfish Immunol Rep | 2023 | 37293549 | PubTator, text mining | PubMed |
| A single-cell level comparison of human inner ear organoids with the human cochlea and vestibular organs. | Cell Rep | 2023 | 37289589 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5818/papers?page=20